Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Background: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk.Objective: To provide evidence-based screening recommendations for comorbidities linked to HS.Methods: Systematic reviews were performed to summarize e...
| Published in: | Journal of the American Academy of Dermatology Vol. 86; no. 5; pp. 1092 - 1102 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | research Journal Article |
| Published: |
Elsevier B.V.
May2022
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156288744&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 156288744 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: May2022 vid: 86 iid: 5 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 156288744 156288744 NLM33493574 156288744 10.1016/j.jaad.2021.01.059 NLM33493574 156288744 ppf: 1092 ppct: 10 formats: tig: atl: Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. aug: au: Garg, Amit Malviya, Neeta Strunk, Andrew Wright, Shari Alavi, Afsaneh Alhusayen, Raed Alikhan, Ali Daveluy, Steven D. Delorme, Isabelle Goldfarb, Noah Gulliver, Wayne Hamzavi, Iltefat Jaleel, Tarannum Kimball, Alexa B. Kirby, Joslyn S. Kirchhof, Mark G. Lester, Janice Lev-Tov, Hadar Lowes, Michelle A. Micheletti, Robert affil: Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York sug: subj: Hidradenitis Suppurativa Epidemiology Pyoderma Gangrenosum Epidemiology Hidradenitis Suppurativa Etiology Hidradenitis Suppurativa Diagnosis Female Comorbidity Canada Human Ferrans and Powers Quality of Life Index Questionnaires Funding Source Female ab: Background: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk.Objective: To provide evidence-based screening recommendations for comorbidities linked to HS.Methods: Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population. The screening recommendation for each comorbidity was informed by the consistency and quality of existing studies, disease prevalence, and magnitude of association, as well as benefits, harms, and feasibility of screening. The level of evidence and strength of corresponding screening recommendation were graded by using the Strength of Recommendation Taxonomy (SORT) criteria.Results: Screening is recommended for the following comorbidities: acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. It is also recommended to screen patients with Down syndrome for HS. The decision to screen for specific comorbidities may vary with patient risk factors. The role of the dermatologist in screening varies according to comorbidity.Limitations: Screening recommendations represent one component of a comprehensive care strategy.Conclusions: Dermatologists should support screening efforts to identify comorbid conditions in HS. pubtype: Academic Journal doctype: research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|